Largest health care pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 health care pharmaceutical companies ranked by net assets, at NOK 843.3B, ahead of Johnson & Johnson (NOK 795.2B) and Sanofi (NOK 772.3B). Figures as of 19 Nov 2026, 16:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerNOK 843.3B
- Median
- NOK 8.6B
- Combined market value
- NOK 48.64T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | NOK 843.3B | NOK 1.54T | NOK 270.45 | 1.17% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | NOK 795.2B | NOK 6.26T | NOK 2,599.91 | 2.24% down | 34% up | ||
| 3 | SanofiSNY · Health Care | NOK 772.3B | NOK 1.08T | NOK 448.69 | 2.36% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | NOK 513B | NOK 3.22T | NOK 1,307.71 | 2.67% down | 45% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | NOK 508.4B | NOK 1.77T | NOK 1,021.92 | 0.30% up | 16% down | ||
| 6 | AstraZenecaAZN · Health Care | NOK 474.6B | NOK 2.65T | NOK 1,705.98 | 2.14% down | 1% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | NOK 453.8B | NOK 666.1B | NOK 208.50 | 0.52% up | 51% up | ||
| 8 | NovartisNVS · Health Care | NOK 449.9B | NOK 2.79T | NOK 1,476.08 | 2.48% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | NOK 304.8B | NOK 949.5B | NOK 9,178.68 | 0.46% down | 28% up | ||
| 10 | Novo NordiskNVO · Health Care | NOK 280.8B | NOK 1.68T | NOK 380.14 | 1.14% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | NOK 258.8B | NOK 11.83T | NOK 13,278.51 | 1.53% down | 33% up | ||
| 12 | GSKGSK · Health Care | NOK 212B | NOK 937B | NOK 467.47 | 1.33% down | 5% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | NOK 182B | NOK 1.31T | NOK 5,149.16 | 1.57% down | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | NOK 180.2B | NOK 1.16T | NOK 569.52 | 1.95% down | 30% up | ||
| 15 | ViatrisVTRS · Health Care | NOK 143.5B | NOK 222.9B | NOK 194.46 | 1.68% down | 99% up | ||
| 16 | Royalty PharmaRPRX · Health Care | NOK 94.7B | NOK 383.2B | NOK 666.46 | 0.48% down | 79% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 77.1B | NOK 454.4B | NOK 389.45 | 5.43% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | NOK 69.2B | NOK 236.5B | NOK 5,552.16 | 1.39% down | 22% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | NOK 63.8B | NOK 130.2B | NOK 260.53 | 0.06% up | 26% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | NOK 59.4B | NOK 119.4B | NOK 616.48 | 2.91% up | 17% up | ||
| 21 | GrifolsGRFS · Health Care | NOK 57B | NOK 55B | NOK 80.84 | 2.13% down | 0% up | ||
| 22 | GenmabGMAB · Health Care | NOK 57B | NOK 313.8B | NOK 508.91 | 2.38% up | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | NOK 44.2B | NOK 280.7B | NOK 387.35 | 2.56% up | 91% up | ||
| 24 | BeOne MedicinesONC · Health Care | NOK 42.5B | NOK 450.2B | NOK 3,941.12 | 0.13% up | 16% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 42.1B | NOK 150.7B | NOK 2,347.96 | 2.83% down | 41% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 39.1B | NOK 120.8B | NOK 144.87 | 0.83% down | 8% up | ||
| 27 | ZoetisZTS · Health Care | NOK 32.5B | NOK 326.9B | NOK 804.55 | 3.59% down | 26% down | ||
| 28 | AlkermesALKS · Health Care | NOK 17.7B | NOK 76.4B | NOK 454.64 | 0.49% down | 66% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | NOK 9.9B | NOK 57B | NOK 2,850.12 | 2.16% down | 50% up | ||
| 30 | Legend BiotechLEGN · Health Care | NOK 9.8B | NOK 31.1B | NOK 160.13 | 1.05% up | 41% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | NOK 8.6B | NOK 87B | NOK 3,112.77 | 4.59% up | 86% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | NOK 7.7B | NOK 195.8B | NOK 1,461.74 | 0.33% up | 66% down | ||
| 33 | Belite BioBLTE · Health Care | NOK 7.5B | NOK 61.3B | NOK 1,508.11 | 1.01% down | 43% up | ||
| 34 | InsmedINSM · Health Care | NOK 7.2B | NOK 308.7B | NOK 1,407.18 | 20.45% up | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | NOK 7B | NOK 92.4B | NOK 973.06 | 1.66% down | 332% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | NOK 6.4B | NOK 84B | NOK 105.03 | 2.57% up | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | NOK 6.3B | NOK 98.1B | NOK 648.95 | 0.64% up | 117% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | NOK 6.3B | NOK 70.7B | NOK 645.88 | 2.30% down | 10% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | NOK 6.2B | NOK 47.8B | NOK 274.67 | 1.28% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | NOK 6B | NOK 80.8B | NOK 1,238.22 | 0.15% down | 51% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 5.9B | NOK 91.9B | NOK 3,954.09 | 1.85% up | 27% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 5.5B | NOK 73.1B | NOK 930.16 | 0.35% up | 129% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | NOK 5.1B | NOK 44.2B | NOK 403.74 | 0.07% up | 86% up | ||
| 44 | ABIVAXABVX · Health Care | NOK 4.9B | NOK 72B | NOK 822.64 | 0.63% up | 32% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | NOK 4.8B | NOK 47.6B | NOK 845.02 | 3.18% up | 108% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | NOK 4.8B | NOK 44.2B | NOK 265.65 | 0.55% down | 63% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | NOK 4.6B | NOK 65.9B | NOK 971.02 | 4.00% up | 255% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 4.5B | NOK 60.5B | NOK 428.17 | 1.84% up | 13% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | NOK 3.2B | NOK 38.7B | NOK 282.32 | 0.58% down | 168% up | ||
| 50 | ErascaERAS · Health Care | NOK 3.2B | NOK 49.1B | NOK 139.94 | 4.29% up | 395% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | NOK 3.1B | NOK 60.5B | NOK 926.45 | 2.71% up | 34% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 1.4B | NOK 80B | NOK 1,153.60 | 0.63% down | 18% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | NOK 1.1B | NOK 46.6B | NOK 485.46 | 0.92% down | 45% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | NOK 861.1M | NOK 69.1B | NOK 1,314.14 | 0.56% up | 6% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -NOK 690.4M | NOK 73.2B | NOK 210.16 | 1.51% down | 90% up | ||
| 56 | VeradermicsMANE · Health Care | -NOK 1.2B | NOK 51.5B | NOK 1,220.91 | 0.27% up | 231% up | ||
| 57 | Ascendis PharmaASND · Health Care | -NOK 1.8B | NOK 170.2B | NOK 2,594.45 | 1.59% down | 29% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -NOK 2B | NOK 49.4B | NOK 591.81 | 0.76% up | 21% down | ||
| 59 | CytokineticsCYTK · Health Care | -NOK 6.4B | NOK 70.3B | NOK 504.57 | 0.82% up | 19% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -NOK 20.3B | NOK 150B | NOK 770.12 | 1.23% up | 21% up | ||
| 61 | AbbVieABBV · Health Care | -NOK 31.9B | NOK 4.86T | NOK 2,751.65 | 1.35% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7521 NOK).
Questions and answers
Which health care pharmaceutical companies rank first by net assets?
Pfizer (NOK 843.3B), Johnson & Johnson (NOK 795.2B) and Sanofi (NOK 772.3B) are the top three of the 61 health care pharmaceutical companies ranked by net assets as of 19 Nov 2026, 16:41 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by net assets have a combined market value of NOK 48.64T as of 19 Nov 2026, 16:41 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.